Patterns of use of sildenafil among commercially insured adults in the United States: 1998–2002

Delate, Thomas; Simmons, Virginia; Motheral, Brenda R.

doi:10.1038/sj.ijir.3901191

Cited by 38 publications

(36 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The largest increase in sildenafil use was found among younger males aged 18-45 years, who had an increase in use of 312% from 1998 to 2002. The study concluded that this large increase in use among a younger population suggested increased use of sildenafil for sexual enhancement or recreational use (Delate et al 2004). Several studies have found increased levels of methamphetamine and sildenafil use among populations of homosexual men (see Swearingen and Klausner 2005 for review).…”

Section: Introductionmentioning

confidence: 93%

Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway

et al. 2006

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 93%

Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Ahora bien, los usuarios de Viagra® no se limitan a los mayores de 40 años ni a aquellos que sufren problemas de erección. Entre 1998 y 2002, el mercado de mayor crecimiento era el de los hombres con edades comprendidas entre los 18 y los 45 años (Delate, Simmons, & Motheral, 2004) que no querían tratar una disfunción sino mejorar lo "normal".…”

Section: Tráfico De Enfermedadesunclassified

¿Normal o patológico? El enfermo imaginario en tierra de nadie

Pérez

2013

Arbor

View full text Add to dashboard Cite

RESUMEN: ¿Es la frontera entre lo normal y lo patológico una realidad o una ficción? ¿Es la enfermedad solo una cuestión de hecho o también de valores? Presentamos aquí algunos ejemplos de cómo supuestas enfermedades pueden ser inventadas y difundidas con fines de lucro (disease mongering) o por la propia dinámica de la investigación médica. Mostramos cómo la frontera entre la salud y la enfermedad es borrosa y está bajo la influencia de representaciones individuales y sociales, de modos de categorización relativos a cada cultura, y del grado de medicalización de la sociedad. Ahora bien, estas consideraciones no le restan realidad sino que le añaden complejidad, porque las construcciones sociales y las experiencias individuales, por ser subjetivas, no son menos reales. Concluimos que la salud y la enfermedad pertenecen simultáneamente a diferentes tipos de realidad, tanto objetivos como subjetivos, y que lo ficticio puede ser real. PALABRAS CLAVE:Enfermedad; Realismo; Constructivismo; Ficción; Tráfico de enfermedades; Objetividad; Realidad subjetiva. ABSTRACT:Is the boundary between the normal and the pathological real or fiction? Are health and disease just a matter of fact or are they value-laden? Here we present some examples of how alleged diseases can be invented and propagated by the industry (disease mongering) or by the methodology of medical science itself. We show that the boundary between health and disease is blurred and depends on individual and social representations, culture relative ways of categorising things and people, and by the society's degree of medicalisation. However, we do not mean that it is not real, rather that it is more complex than expected, as the subjectivity of social constructions and individual experiences makes them no less real. Finally, we conclude that health and disease belong to both objective and subjective kinds of reality, so the fictional can be real.

show abstract

“…A review showed that several studies have evidenced the efficacy and safety of these drugs 1 . In the United States, the prevalence of sildenafil use increased from 0.8% to 1.4% (84%) in the first four years after its introduction to the market 2 . It is estimated a growing use of PDE-5i drugs in Brazil, which trade moves annually more than 70 million dollars with high investment by the pharmaceutical industry.³ Furthermore, there is a parallel trade of non-regulated drugs for erectile dysfunction.…”

Section: Introductionmentioning

confidence: 99%